在急性不补偿性心力衰竭的住院治疗期间,尿剂定位的模式
Griffin Bullock1, Joshua A Jacobs2, Jessica R Carey3
1Department of Biomedical Sciences, Division of Clinical Informatics, Cedars Sinai Medical Center, Los Angeles, CA.
American heart journal
|December 29, 2024
概括
对于急性不补偿性心力衰竭 (ADHF) 的利尿策略有很大的不同. 尿液治疗的延迟增加了住院时间,但没有影响30天的再入院,这表明与结果相关的差异.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 由于急性不补偿性心力衰竭 (ADHF) 的住院率不断上升,需要对当前的治疗实践进行分析.
- 对ADHF管理的最佳尿剂策略尚不清楚,影响患者的治疗结果和医疗保健资源的利用.
研究的目的:
- 分析因ADHF住院的成年人尿液实践模式.
- 评估利尿剂时间与住院时间 (LOS) 和30天再入院率之间的关联.
主要方法:
- 在2014年至2021年期间,对4,298名成人ADHF住院病例进行了回顾性队列分析.
- 多变量回归分析,以评估与LOS和30天再入院相关的利尿剂治疗开始,升级和最大剂量的时间.
主要成果:
- 到最大的利尿剂治疗的中位时间为1.8天;初始的IV循环利尿剂量为3.6小时.
- 增加初始,第二次和最大利尿剂治疗的时间与较长的LOS相关.
- 在利尿剂时间和30天再入院率之间没有发现显著的关联.
结论:
- 在ADHF患者的利尿策略中存在显著的差异.
- 延迟的利尿干预与增加的LOS有关,但不是30天的再入院.
- 需要进一步的研究来调查特定的利尿剂策略对ADHF患者结果的影响.
更多相关视频
相关概念视频
Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339
Renal Failure: Dose Adjustments
63
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
63
Heart Failure Drugs: Inotropic Agents
516
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
382
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Antihypertensive Drugs: Potassium-Sparing Diuretics
448
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
448


